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Abstract
Celiac disease (CD) is an autoimmune disorder of the sm­
all intestine that occurs in genetically predisposed people 
at all ages. However, it can be associated also to other im­
munopathological disorders, and may be associated with 
abnormal histology in segments of the gut other than the 
small bowel including colonic inflammation. While guide­
lines for endoscopic investigation of the jejunum are well 
defined, no indication is defined for colonic investigation. 
We describe four cases of concurrent CD and microscopic 
colitis (MC) diagnosed at our department over a 10­year 
period and analyzed the main features and outcomes of 
CD in this setting. The symptoms of these patients were 
improved initially by a gluten­free diet before the onset 
of MC symptoms. Two of the patients were siblings and 
had an atypical form of CD. The other two patients with 
CD and MC also presented with fibrosing alveolitis and 
were anti­Saccharomyces cerevisiae antibody positive. 
The co­existence of immune­mediated small bowel and 
colonic inflammatory and pulmonary diseases are not 
well­known, and no systematic approach has been used 
to identify the lifelong patterns of these immune­based 
diseases. Patients can develop, or present with CD at any 
stage in life, which can co­exist with other gastrointesti­
nal diseases of (auto­) immune origin. In addition, the fa­
milial co­existence and prevalence of MC in patients with 
a prior diagnosis of CD are unclear. Clinicians managing 
celiac disease should be aware of these associations and 
understand when to consider colon investigation.
© 2011 Baishideng. All rights reserved.
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INTRODUCTION
Celiac disease (CD) is an immune-mediated disorder, 
an autoimmune enteropathy, triggered by the ingestion 
of  gluten in genetically susceptible persons. The dis-
ease primarily affects the gastrointestinal tract and is 
characterized by chronic inflammation of  the small bowel 
mucosa that may result in atrophy of  intestinal villi, ma-
labsorption, and a variety of  clinical manifestations. Of  
genetic factors, the strongest recognized association is 
with HLA-DQ2 and/or -DQ8: 95%-100% of  the patients 
carry these molecules. Dietary glutens interact with 
these HLA molecules to activate an abnormal mucosal 
immune response and induce tissue damage. Most affected 
individuals experience remission after gluten is excluded 
from their diet. 
The diagnosis of  CD is established by serologic test-
ing, biopsy evidence of  villous atrophy, and improvement 
of  symptoms on a gluten-free diet. Avoidance of  gluten 
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exposure is crucial for CD patients to reduce the risk of  
complications so the follow-up serological assessment of  
treatment effectiveness should be added to be sure of  a 
good compliance.  
There are atypical forms of  CD. For example, silent 
CD is found in individuals who are asymptomatic but have 
a positive serologic test and villous atrophy on biopsy, and 
latent CD is defined by a positive serology but no villous 
atrophy on biopsy. These individuals are asymptomatic, but 
later may develop symptoms and/or histological changes[1]. 
The late concordance in the appearance of  CD in mono-
zygotic twins also suggests that the disorder may remain in 
the latent stage for a long time[2,3]. Small bowel villous atrop-
hy with crypt hyperplasia and recovery of  the lesion on a 
gluten-free diet suggest that villous atrophy comprises only 
the end stage of  the clinical course of  the disease and that 
CD clearly develops gradually from mucosal inflammation 
to crypt hyperplasia and finally to overt villous atrophy. 
A typical feature of  CD, in addition to mucosal changes, 
is gluten-dependent serum IgA class autoantibodies against 
transglutaminase 2 (TG2). These serum autoantibodies, 
endomysial and TG2, are powerful tools in disclosing CD 
with overt villous atrophy. Furthermore, positive serum 
celiac autoantibodies can predict impending CD in many 
patients evincing normal small bowel mucosal villous ar-
chitecture. Hence, patients having “false-positive” celiac 
autoantibodies in serum are in fact at risk of  developing 
overt CD. Some patients with positive serum endomysial 
or tissue TG2 antibodies may still seroconvert negatively 
during follow-up. However, it is well recognized that se-
rum celiac autoantibodies in some cases fluctuate before a 
patient eventually develops overt CD after a longer follow-
up period. The reason for this still remains obscure.
Transglutaminases are a family of  8 currently known 
calcium-dependent enzymes that catalyze the cross-linking 
or deamidation of  proteins and are involved in important 
biological processes such as wound healing, tissue repair, fi-
brogenesis, apoptosis, inflammation, and cell-cycle control. 
Therefore, they play an important role in the pathomecha-
nisms of  autoimmune, inflammatory, and degenerative 
diseases, many of  which affect the gastrointestinal system. 
Transglutaminase 2 is prominent, since it is central to the 
pathogenesis of  CD, and modulates inflammation and fi-
brosis in inflammatory bowel and chronic liver diseases[4]. 
Respiratory disease and subclinical pulmonary abnormali-
ties are the recognized complications of  both CD and 
inflammatory bowel disease (IBD) but the mechanisms of  
lung disease in CD differ from that in IBD and support the 
hypothesis of  a common mucosal defect in lung and small 
intestine in CD that allow increased permeability[5].
Lymphocytic colitis (LC), together with collagenous 
colitis (CC), is included under the umbrella term “micro-
scopic colitis” (MC), in which chronic gastrointestinal 
symptoms, including diarrhea, abdominal pain, fecal urgen-
cy, incontinence, and nausea, are not associated with endo-
scopic or radiological alterations. It is not known whether 
LC and CC are two different diseases or distinct manifesta-
tions of  the same clinical condition. Data on pathophysiol-
ogy conflict and different hypotheses refer to genetic pre-
disposition, immune dysregulation, autoimmunity, bile acid 
malabsorption, infection, and drug effect. Familial occur-
rence of  MC has been identified in some families[6-13]. The 
central role of  an altered immune system in MC pathogen-
esis is supported by the association with several conditions 
in which an immune dysregulation is involved, such as CD, 
rheumatoid arthritis, and hypo- and hyperthyroidism. Up to 
now, it has not been clear whether CC (or LC) is a distinct 
entity or only an epiphenomenon of  another disease that 
leads to thickening of  the collagen layer. However, whether 
MC (both CC and LC) is an autoimmune disease has not 
been conclusively established[14]. Diagnosis of  MC can be 
established only by colonic biopsies and subsequent histo-
pathological examination, when an increase in inflamma-
tory infiltration and/or a thickening of  the collagen layer 
are found. A number of  papers have documented an asso-
ciation between CD and MC[15-18]. However, the prevalence 
of  MC in patients with a prior diagnosis of  CD is unclear, 
but it does feature prominently in several series of  patients 
with CD who have persisting symptoms despite gluten 
exclusion. When continuing gluten ingestion, inadvertent 
or covert, has been excluded, colon investigation should be 
considered as part of  the investigation of  these patients. 
The link may be genetic, at least in part. Both types of  MC 
are known to resolve spontaneously in a majority of  cases. 
Data are limited regarding pharmacological therapies, but 
budesonide appears best documented as showing an effi-
cacy against CC and MC[19]. 
We report here 4 cases with sequential development of  




A 42-year-old female with a previous history of  both 
cognitive and neurovegetative symptoms of  depression, 
including depressed mood, anhedonia, feelings of  wor-
thlessness, low energy, troubled sleep, and poor concen-
tration, was evaluated in the local medical center for com-
plaints of  watery diarrhea. She had longstanding lactose 
intolerance for which she was taking a lactose-free diet. As 
her mother had manifestations of  CD, enteroscopy was 
performed. However, the first endoscopic and histological 
evaluation showed no duodenal mucosal alterations 
(Marsh 0). Six months later, endoscopic findings were 
persistent and duodenal biopsies were taken which were 
not diagnostic for CD, and biochemical laboratory tests 
were within normal ranges. She was then referred to our 
clinic and additional laboratory tests showed increased 
antibody titers against gliadin, endomysium, and tTG. Her 
psychiatric disease was controlled after treatment and then 
remained stable. She was given a gluten-free diet, which 
resolved her diarrhea and allowed her to regain her lost 
body weight. Five years later, the patient presented with 
watery diarrhea occurring 8-10 times daily and mild body 
weight loss. At the beginning, this condition was associated 
with urgency, nocturnal stools, abdominal cramping, 
nausea, mild body weight loss, and fatigue, and persisted 
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despite strict adherence to the gluten- and lactose-free diet. 
With the loss of  patience of  the diet and of  her symptoms 
she broke her diet and clinical signs remained. Small bo-
wel biopsies at upper endoscopy demonstrated nothing 
(Marsh 0) but the gluten panel was unambiguously positive. 
Stool cultures and Clostridium difficile toxin assay were 
negative. After consultation with dietitians, the patient was 
maintained on a gluten- and lactose-free diet for six months 
but with mild improvement. Colonoscopy was performed 
later, and biopsies from her colon demonstrated LC. Her 
symptoms responded partially to mesalazine treatment over 
the subsequent two months, at which point her medical 
therapy was changed to budesonide (9 mg/d). After she 
was put on budesonide with a strict diet, both abdominal 
complaints and psychiatric problems resolved (Figure 1).
Case 2
A 45-year-old woman with suspected irritable bowel syn-
drome was admitted to the hospital. Her bowel movements 
increased from one to six or eight a day with watery stools. 
She did not note any mucus or blood in the stool and 
could not identify any alleviating or aggravating factors. 
She consumed a normal diet, including meat, wheat, 
and dairy. Over-the-counter anti-diarrheal medications 
did not relieve her symptoms. She had no fevers, chills, 
or night sweats, but body weight loss. Her medical hist-
ory included major depression for 10 years, which was 
controlled after treatment and remained stable at admis-
sion. Results of  basic laboratory tests, including thyroid-
stimulating hormone (TSH), complete blood count, blood 
chemistries, renal function, and liver function, were nor-
mal. Colonoscopy showed normal mucosa as far as the 
cecum. Colonic biopsy revealed a mildly expanded lamina 
propria and intraepithelial lymphocytosis with significantly 
thickening of  the subepithelial collagen table. This set of  
features was consistent with CC, a variant of  MC. Her 
symptoms were eventually controlled after a 6-mo course 
of  oral budesonide (9 mg) and ongoing intermittent use 
of  loperamide (Imodium). Six years later, similar problems 
with body weight loss caused her to be hospitalized at our 
clinic. A detailed previous history unraveled the familial 
connection with Case 1 and her mother with known CD. 
Psychiatric disease was controlled, so control and further 
GI investigations were organized. The histopathology 
report of  colonic biopsy showed aspecific inflammation 
without MC. Further laboratory investigation revealed 
that the entire celiac antibody panel was positive. Results 
of  duodenal biopsy did not reveal typical lymphocyte 
infiltration, crypt hyperplasia, and villous atrophy but 
normal mucosal architecture, without significant intraepi-
thelial lymphocytic infiltration (Marsh 0). The diagnosis 
was latent CD, as the patient had abnormal antibody blood 
tests for CD but normal small intestines. After she was put 
on a strict gluten-free diet, both abdominal complaints and 
psychiatric problems resolved (Figure 1).
Case 3
A 56-year-old woman with a previous history of  chronic 
(non-specific) colitis and fibrosing alveolitis was referred 
to our hospital from an outside hospital because of  contin-
ued signs and symptoms of  CD that persisted despite self-
reported adherence to a gluten-free diet. The patient rep-
orted abdominal pain, bowel distension, and body weight 
loss over the past few years. Diagnosis of  CD was made 4 
years ago, based on the small bowel biopsy results showing 
evidence of  villous blunting with increased chronic infl-
ammatory cells, positive laboratory tests, and typical 
gastrointestinal signs and symptoms with negative stool 
cultures and Clostridium difficile toxin assay. Repeated 
laboratory tests showed elevated antibodies against gliadin, 
endomysium, and tTG, and small bowel biopsy proved 
villous atrophy. The patient met with a nutritionist and 
implemented recommended dietary changes to eliminate 
gluten. Her symptoms temporarily improved with her 
bowel function returned to normal, but after a short time 
her symptoms recurred. Results of  further tests excluded 
conditions known to complicate or coexist with CD, 
including bacterial overgrowth and lactose intolerance. 
Because of  chronic watery stools, a colonoscopy was do-
ne with random biopsies from the colon for histological 
investigations. Based on the typical picture of  prominent 
intraepithelial lymphocytes but no thickened collagenous 
layer, the pathologist diagnosed her with LC. She was 
started on strict gluten-free diet and budesonide with 
success. Five years later, she was free of  complaints of  
CD and LC. 
Case 4
A man at age 31, with a previous history of  bronchial ast-
hma, was investigated for abdominal pain, chronic watery 
diarrhea, and body weight loss with negative stool samples 
(both the cultures and Clostridium difficile toxin assay). 
Findings from an upper gastrointestinal endoscopy were 
normal, but distal duodenal biopsies showed subtotal 
villous atrophy, inflammatory infiltration of  the lamina 
propria, and an increase in intraepithelial lymphocytes. 
Based on the histology and positive laboratory tests, CD 
was diagnosed and the patient was started on a gluten-
free diet. Abdominal pain ceased but he did not gain body 
weight and diarrhea remained a problem. Compliance 
with a gluten-free diet was confirmed by the assessment 
of  dietitians. Repeated biopsies of  the duodenal mucosa 
showed mild improvement in villous atrophy but serology 












Figure 1  Family of cases 1 and 2.
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was negative. Four years later, a dietitian again confirmed 
adherence to a strict gluten-free diet and colonic biopsies 
showed no alteration. A barium follow-through showed 
mild jejunal and rather featureless ileal mucosa but no 
obstructive lesion of  the small bowel, nothing abnormal 
was seen on an ultrasound scan of  the abdomen. Because 
of  bloody stools and in view of  his worsening symptoms 
despite the gluten-free diet, repeated colonoscopy with 
random biopsies was done for histological investigations 
from ileal and colonic samples. Both proved a submucosal 
thickened collagen layer, thus the diagnosis of  collagenous 
entero-colitis (with CD) was made. He was started on 
mesalazine and budesonide but without e’clat. The next 
step was methylprednisolone, initially 32 mg/d, and then 
the dose was decreased to 4 mg/d. This therapy was 
continued with corticosteroids for three months. Over the 
next year, his clinical condition improved, with resolution 
of  his diarrhea and a body weight gain of  3 kg. Three 
years later, his symptoms recurred. Results of  further tests 
excluded conditions known to complicate or coexist with 
CD, including bacterial overgrowth and lactose intolerance. 
Repeated biopsies excluded collagenous entero-colitis, thus 
fibrosing alveolitis was diagnosed by the pulmonologist 
based on the lung function, laboratory and radio-imaging 
tests, chest X-ray, and high-resolution CT scanning 
(HRCT). Because the abdominal symptoms of  the patient 
were refractory to treatment, he was treated again with 
budesonide and his clinical condition improved. 
The diagnoses of  CD, MC, and fibrosing alveolitis in all 
cases were made according to the formally accepted crite-
ria. Two independent pathologists certified the diagnosis of  
MC by verifying the subsequent sections and completing 
the check with additional investigations (intraepithelial lym-
phocytes, tenascin labeling of  the collagen layer, mast cells, 
and other lamina propria cell components). Fibrosing al-
veolitis was proved by HRCT and upon the ATS/ERS clin-
ical criteria. The laboratory tests were performed. In brief, 
the HLA-DQ alleles were determined from whole blood 
samples by PCR with sequence-specific primers, traditional 
IgG and IgA AGA were detected by ELISA (α-gliatest IgG 
and IgA; Eurospital, Trieste, Italy), anti-tTG was measured 
by ELISA using recombinant human tissue transglutamin-
ase as an antigen (EutTG, Eurospital), IgG and IgA EmA 
were investigated by indirect immunofluorescence using 
human umbilical cord cryostat sections prepared in our 
laboratory as a substrate, and both serum IgG and IgA 
levels in anti-Saccharomyces cerevisiae antibody (ASCA) 
were evaluated (separately) according to the manufacturer’s 
protocol (ASCA IgG, ASCA IgA, QUANTA Lite, INOVA 
Diagnostics) (Table 1).
DISCUSSION
Is CD much ado about nothing? This report presents four 
cases of  CD with MC. The symptoms of  these patients 
were improved initially by a gluten-free diet before the onset 
of  MC symptoms. Their history indicates and underlines 
that patients can develop, or present with CD at any stage 
in life and that CD can co-exist with other gastrointestinal 
diseases of  an (auto-) immune origin. Patients with CD 
can fail to respond to the initial introduction of  a gluten-
free diet or have a recurrence of  symptoms after initial 
improvement, despite maintaining gluten exclusion. The 
most feared causes of  either scenario are complicating 
malignancy, notably enteropathy-associated T-cell lymp-
homa, or refractory sprue. Other causes of  persistent sy-
mptoms with increased prevalence in CD include lactose 
intolerance, exocrine pancreatic insufficiency, bacterial 
overgrowth, and microscopic (lymphocytic or collagenous) 
colitis. Thus, in patients whose symptoms fail to respond 
or who later relapse, despite the exclusion of  gluten from 
their diet, the possibility of  additional pathology should be 
considered and colonoscopy should, therefore, be part of  
the follow-up in patients who present with chronic watery 
diarrhea, even if  initial tests indicate only CD.
Relations between CD and ulcerative ileojejunitis, 
polymyositis, and fibrosing alveolitis have been previously 
described[20,21], and it is of  interest that an auto-immune 
pathophysiology has been implicated in each of  these con-
ditions. An association has been suggested between CD 
and diffuse interstitial lung disease of  the hypersensitivity 
pneumonitis type in several reports from Europe[22]. A case 
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Table 1  Summary of the cases
Case 1 Case 2 Case 3 Case 4
Sex/birth (yr) Female/1956 Female/1955 Female/1945 Male/1964




Partial villous atrophy (Marsh 3A) 
according to the modified Marsh criteria
Total villous atrophy (Marsh 3C) 
according to the modified Marsh criteria
HLA-DQ2 Present Present Present Present
lgA TTG + + + +
lgG/lgA EMA  +/+  -/+  -/+  +/+
lgG/lgA Gliadin  +/+  -/+  -/+  +/+
lgG/lgA ASCA  -/-  -/-  +/+  +/+
Celiac disease Latent Latent Manifest Manifest
Colon histology Lymphocytic colitis Collagenous colitis Lymphocytic colitis Collagenous colitis
Therapy GFD and budesonide GFD and budesonide GFD and budesonide GFD and budesonide
Other disease - - Fibrosing alveolitis Fibrosing alveolitis
Laboratory tests and histology of the small bowel before gluten-free diet, colon histology after gluten-free diet, therapy, and concomitant lung disease. TTG: 
Tissue transglutaminase; EMA: Endomysial antibody; ASCA: Anti-saccharomyces cerevisiae antibody; GFD: Gluten-free diet; HLA: Human leukocyte antigen.
of  lymphocytic bronchoalveolitis and CD with improve-
ment following a gluten free diet was also reported[23]. 
Our patients with manifestations of  CD and MC 
presented with fibrosing alveolitis and were ASCA (anti-
yeast antibodies to yeast antigens that are found in bread 
and other cereal derived products) positive (both IgG and 
IgA types). Previously, ASCA positivity was shown to be 
evident in up to 40%-60% of  CD patients and 13%-15% 
of  MC patients, but its implication is disputed[24]. A pos-
sible connection between alveolitis and ASCA is also 
not known. Only one case of  a Japanese patient was 
published: lung biopsy specimens showed alveolitis and 
serum-precipitating antibody gave a positive reaction for 
an extract from S. cerevisiae[25].
In conclusion, the co-existence of  immune-mediated 
small bowel and colonic inflammatory diseases (i.e. CD 
and IBD) and pulmonary diseases is not well-known 
and no systematic approach has been used to identify 
the life-long patterns of  these immune-based diseases[26]. 
Such information may be useful for both disease preven-
tion and treatment approaches. Clinicians managing CD 
should be aware of  these associations and when to con-
sider colon investigation.
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